<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38541055</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>A Prospective Study on Neural Biomarkers in Patients with Long-COVID Symptoms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">313</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14030313</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">this prospective observational study aims to assess serum levels of glial fibrillary acidic protein (GFAP), s100b, and total Tau in long-COVID patients, exploring correlations with symptoms, cognitive decline, mental health, and quality of life.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Long-COVID patients visiting our outpatient clinic (February 2021-December 2022) were screened alongside age- and sex-matched controls. GFAP, s100b, and total Tau in serum were measured with ELISA. Cognitive function, depression, anxiety, post-traumatic stress disorder, and quality of life were evaluated using MoCA, HADS (depression and anxiety), IES-R, and SF-36, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Sixty-five long-COVID patients and 20 controls were included. GFAP levels were significantly higher in long-COVID patients (<i>p</i> = 0.031), though not correlating with the presence of long-COVID symptoms. S100b and total Tau showed no significant differences between patients and controls. Nervous system-related symptoms were reported in 47% of patients. High rates of cognitive decline (65.9%), depression (32.2%), anxiety (47.5%), and post-traumatic stress disorder (44.1%) were observed. Over 80% of the study population scored below normative cutoffs for SF-36, indicating a significant impact on quality of life.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">in this long-COVID cohort with substantial psychological and cognitive symptoms, GFAP levels were elevated compared to controls, though not correlating with the presence of long-COVID symptoms.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Vrettou</LastName><ForeName>Charikleia S</ForeName><Initials>CS</Initials><Identifier Source="ORCID">0000-0002-1067-8849</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassiliou</LastName><ForeName>Alice G</ForeName><Initials>AG</Initials><Identifier Source="ORCID">0000-0003-4984-0476</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Keskinidou</LastName><ForeName>Chrysi</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4047-3588</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mourelatos</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asimakos</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0425-6543</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spetsioti</LastName><ForeName>Stavroula</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9053-3219</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diamantopoulos</LastName><ForeName>Aristidis</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jahaj</LastName><ForeName>Edison</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-7306-713X</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonoglou</LastName><ForeName>Archontoula</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katsaounou</LastName><ForeName>Paraskevi</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8736-619X</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vassiliadi</LastName><ForeName>Dimitra A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0002-3403-8977</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology Diabetes and Metabolism, National Expertise Center for Rare Endocrine Diseases, Evangelismos Hospital, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kotanidou</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2508-500X</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dimopoulou</LastName><ForeName>Ioanna</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-2219-7292</Identifier><AffiliationInfo><Affiliation>First Department of Critical Care Medicine, Evangelismos Hospital, Medical School, National &amp; Kapodistrian University of Athens, 10676 Athens, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">GFAP</Keyword><Keyword MajorTopicYN="N">health-related quality of life</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">s100b</Keyword><Keyword MajorTopicYN="N">total Tau</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>28</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38541055</ArticleId><ArticleId IdType="pmc">PMC10971257</ArticleId><ArticleId IdType="doi">10.3390/jpm14030313</ArticleId><ArticleId IdType="pii">jpm14030313</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ellul M.A., Benjamin L., Singh B., Lant S., Michael B.D., Easton A., Kneen R., Defres S., Sejvar J., Solomon T. Neurological Associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;783. doi: 10.1016/S1474-4422(20)30221-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul M., Varatharaj A., Nicholson T.R., Pollak T.A., Thomas N., Easton A., Zandi M.S., Manji H., Solomon T., Carson A., et al. Defining Causality in COVID-19 and Neurological Disorders. J. Neurol. Neurosurg. Psychiatry. 2020;91:811&#x2013;812. doi: 10.1136/jnnp-2020-323667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323667</ArticleId><ArticleId IdType="pmc">PMC7299654</ArticleId><ArticleId IdType="pubmed">32503883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tom J., Bao M., Tsai L., Qamra A., Summers D., Carrasco-Triguero M., McBride J., Rosenberger C.M., Lin C.J.F., Stubbings W., et al. Prognostic and Predictive Biomarkers in Patients with Coronavirus Disease 2019 Treated with Tocilizumab in a Randomized Controlled Trial&#x2217;. Crit. Care Med. 2022;50:398&#x2013;409. doi: 10.1097/CCM.0000000000005229.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005229</ArticleId><ArticleId IdType="pmc">PMC8855771</ArticleId><ArticleId IdType="pubmed">34612846</ArticleId></ArticleIdList></Reference><Reference><Citation>Paniz-Mondolfi A., Bryce C., Grimes Z., Gordon R.E., Reidy J., Lednicky J., Sordillo E.M., Fowkes M. Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) J. Med. Virol. 2020;92:699&#x2013;702. doi: 10.1002/jmv.25915.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25915</ArticleId><ArticleId IdType="pmc">PMC7264598</ArticleId><ArticleId IdType="pubmed">32314810</ArticleId></ArticleIdList></Reference><Reference><Citation>Savarraj J., Park E.S., Colpo G.D., Hinds S.N., Morales D., Ahnstedt H., Paz A.S., Assing A., Liu F., Juneja S., et al. Brain Injury, Endothelial Injury and Inflammatory Markers Are Elevated and Express Sex-Specific Alterations after COVID-19. J. Neuroinflammation. 2021;18:277. doi: 10.1186/s12974-021-02323-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02323-8</ArticleId><ArticleId IdType="pmc">PMC8627162</ArticleId><ArticleId IdType="pubmed">34838058</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin P., Collongues N., Baloglu S., Bedo D., Bassand X., Lavaux T., Gautier-Vargas G., Keller N., Kremer S., Fafi-Kremer S., et al. Cytokine Release Syndrome-Associated Encephalopathy in Patients with COVID-19. Eur. J. Neurol. 2021;28:248&#x2013;258. doi: 10.1111/ene.14491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14491</ArticleId><ArticleId IdType="pmc">PMC7461405</ArticleId><ArticleId IdType="pubmed">32853434</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano J.B., Murthy S., Marshall J.C., Relan P., Diaz J.V. A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. Lancet Infect. Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Schou T.M., Joca S., Wegener G., Bay-Richter C. Psychiatric and Neuropsychiatric Sequelae of COVID-19&#x2014;A Systematic Review. Brain Behav. Immun. 2021;97:328&#x2013;348. doi: 10.1016/j.bbi.2021.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.07.018</ArticleId><ArticleId IdType="pmc">PMC8363196</ArticleId><ArticleId IdType="pubmed">34339806</ArticleId></ArticleIdList></Reference><Reference><Citation>Desai A.D., Lavelle M., Boursiquot B.C., Wan E.Y. Long-Term Complications of COVID-19. Am. J. Physiol. Cell Physiol. 2022;322:C1&#x2013;C11. doi: 10.1152/ajpcell.00375.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00375.2021</ArticleId><ArticleId IdType="pmc">PMC8721906</ArticleId><ArticleId IdType="pubmed">34817268</ArticleId></ArticleIdList></Reference><Reference><Citation>Michetti F., Corvino V., Geloso M.C., Lattanzi W., Bernardini C., Serpero L., Gazzolo D. The S100B Protein in Biological Fluids: More than a Lifelong Biomarker of Brain Distress. J. Neurochem. 2012;120:644&#x2013;659. doi: 10.1111/j.1471-4159.2011.07612.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07612.x</ArticleId><ArticleId IdType="pubmed">22145907</ArticleId></ArticleIdList></Reference><Reference><Citation>Pase M.P., Beiser A.S., Himali J.J., Satizabal C.L., Aparicio H.J., Decarli C., Ch&#xea;ne G., Dufouil C., Seshadri S. Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes. JAMA Neurol. 2019;76:598&#x2013;606. doi: 10.1001/jamaneurol.2018.4666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.4666</ArticleId><ArticleId IdType="pmc">PMC6515589</ArticleId><ArticleId IdType="pubmed">30830207</ArticleId></ArticleIdList></Reference><Reference><Citation>Klinkhammer S., Horn J., Duits A.A., Visser-Meily J.M.A., Verwijk E., Slooter A.J.C., Postma A.A., van Heugten C.M., Aries M.J.H., van Bussel B.C.T., et al. Neurological and (Neuro)Psychological Sequelae in Intensive Care and General Ward COVID-19 Survivors. Eur. J. Neurol. 2023;30:1880&#x2013;1890. doi: 10.1111/ene.15812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15812</ArticleId><ArticleId IdType="pubmed">37010152</ArticleId></ArticleIdList></Reference><Reference><Citation>Messing A., Brenner M. GFAP at 50. ASN Neuro. 2020;12:1&#x2013;23. doi: 10.1177/1759091420949680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759091420949680</ArticleId><ArticleId IdType="pmc">PMC7440737</ArticleId><ArticleId IdType="pubmed">32811163</ArticleId></ArticleIdList></Reference><Reference><Citation>Needham E.J., Ren A.L., Digby R.J., Norton E.J., Ebrahimi S., Outtrim J.G., Chatfield D.A., Manktelow A.E., Leibowitz M.M., Newcombe V.F.J., et al. Brain Injury in COVID-19 Is Associated with Dysregulated Innate and Adaptive Immune Responses. Brain. 2022;145:4097&#x2013;4107. doi: 10.1093/brain/awac321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac321</ArticleId><ArticleId IdType="pmc">PMC9494359</ArticleId><ArticleId IdType="pubmed">36065116</ArticleId></ArticleIdList></Reference><Reference><Citation>Donato R., Cannon B.R., Sorci G., Riuzzi F., Hsu K., Weber D.J., Geczy C.L. Functions of S100 Proteins. Curr. Mol. Med. 2013;13:24&#x2013;57. doi: 10.2174/156652413804486214.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156652413804486214</ArticleId><ArticleId IdType="pmc">PMC3707951</ArticleId><ArticleId IdType="pubmed">22834835</ArticleId></ArticleIdList></Reference><Reference><Citation>Thelin E.P., Nelson D.W., Bellander B.M. A Review of the Clinical Utility of Serum S100B Protein Levels in the Assessment of Traumatic Brain Injury. Acta Neurochir. 2017;159:209&#x2013;225. doi: 10.1007/s00701-016-3046-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00701-016-3046-3</ArticleId><ArticleId IdType="pmc">PMC5241347</ArticleId><ArticleId IdType="pubmed">27957604</ArticleId></ArticleIdList></Reference><Reference><Citation>Aceti A., Margarucci L.M., Scaramucci E., Orsini M., Salerno G., Di Sante G., Gianfranceschi G., Di Liddo R., Valeriani F., Ria F., et al. Serum S100B Protein as a Marker of Severity in COVID-19 Patients. Sci. Rep. 2020;10:18665. doi: 10.1038/s41598-020-75618-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75618-0</ArticleId><ArticleId IdType="pmc">PMC7596559</ArticleId><ArticleId IdType="pubmed">33122776</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;glsberger S., Cordero-Maldonado M.L., Antony P., Forster J.I., Garcia P., Buttini M., Crawford A., Glaab E. Gender-Specific Expression of Ubiquitin-Specific Peptidase 9 Modulates Tau Expression and Phosphorylation: Possible Implications for Tauopathies. Mol. Neurobiol. 2017;54:7979&#x2013;7993. doi: 10.1007/s12035-016-0299-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0299-z</ArticleId><ArticleId IdType="pmc">PMC5684262</ArticleId><ArticleId IdType="pubmed">27878758</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavares-J&#xfa;nior J.W.L., de Souza A.C.C., Borges J.W.P., Oliveira D.N., Siqueira-Neto J.I., Sobreira-Neto M.A., Braga-Neto P. COVID-19 Associated Cognitive Impairment: A Systematic Review. Cortex. 2022;152:77&#x2013;97. doi: 10.1016/j.cortex.2022.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2022.04.006</ArticleId><ArticleId IdType="pmc">PMC9014565</ArticleId><ArticleId IdType="pubmed">35537236</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreddine Z.S., Phillips N.A., B&#xe9;dirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. J. Am. Geriatr. Soc. 2005;53:695&#x2013;699. doi: 10.1111/j.1532-5415.2005.53221.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Olss&#xf8;n I., Mykletun A., Dahl A.A. The Hospital Anxiety and Depression Rating Scale: A Cross-Sectional Study of Psychometrics and Case Finding Abilities in General Practice. BMC Psychiatry. 2005;5:46. doi: 10.1186/1471-244X-5-46.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-244X-5-46</ArticleId><ArticleId IdType="pmc">PMC1343544</ArticleId><ArticleId IdType="pubmed">16351733</ArticleId></ArticleIdList></Reference><Reference><Citation>Creamer M., Bell R., Failla S. Psychometric Properties of the Impact of Event Scale-Revised. Behav. Res. Ther. 2003;41:1489&#x2013;1496. doi: 10.1016/j.brat.2003.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brat.2003.07.010</ArticleId><ArticleId IdType="pubmed">14705607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ware J.E., Sherbourne C.D. The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection. Med. Care. 1992;30:473&#x2013;483. doi: 10.1097/00005650-199206000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005650-199206000-00002</ArticleId><ArticleId IdType="pubmed">1593914</ArticleId></ArticleIdList></Reference><Reference><Citation>Telser J., Grossmann K., Weideli O.C., Hillmann D., Aeschbacher S., Wohlwend N., Velez L., Kuhle J., Maleska A., Benkert P., et al. Concentrations of Serum Brain Injury Biomarkers Following SARS-CoV-2 Infection in Individuals with and without Long-COVID&#x2014;Results from the Prospective Population-Based COVI-GAPP Study. Diagnostics. 2023;13:2167. doi: 10.3390/diagnostics13132167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13132167</ArticleId><ArticleId IdType="pmc">PMC10340196</ArticleId><ArticleId IdType="pubmed">37443561</ArticleId></ArticleIdList></Reference><Reference><Citation>Bark L., Larsson I.M., Wallin E., Simr&#xe9;n J., Zetterberg H., Lipcsey M., Frithiof R., Rostami E., Hultstr&#xf6;m M. Central Nervous System Biomarkers GFAp and NfL Associate with Post-Acute Cognitive Impairment and Fatigue Following Critical COVID-19. Sci. Rep. 2023;13:13144. doi: 10.1038/s41598-023-39698-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-39698-y</ArticleId><ArticleId IdType="pmc">PMC10423244</ArticleId><ArticleId IdType="pubmed">37573366</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boni L., Odainic A., Gancarczyk N., Kaluza L., Strassburg C.P., Kersting X.A.K., Johnson J.M., W&#xfc;llner U., Schmidt S.V., Nattermann J., et al. No Serological Evidence for Neuronal Damage or Reactive Gliosis in Neuro-COVID-19 Patients with Long-Term Persistent Headache. Neurol. Res. Pract. 2022;4:53. doi: 10.1186/s42466-022-00217-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-022-00217-5</ArticleId><ArticleId IdType="pmc">PMC9618412</ArticleId><ArticleId IdType="pubmed">36310154</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorci G., Giovannini G., Riuzzi F., Bonifazi P., Zelante T., Zagarella S., Bistoni F., Donato R., Romani L. The Danger Signal S100B Integrates Pathogen- and Danger-Sensing Pathways to Restrain Inflammation. PLoS Pathog. 2011;7:e1001315. doi: 10.1371/journal.ppat.1001315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001315</ArticleId><ArticleId IdType="pmc">PMC3053348</ArticleId><ArticleId IdType="pubmed">21423669</ArticleId></ArticleIdList></Reference><Reference><Citation>Vrettou C.S., Vassiliou A.G., Pratikaki M., Keskinidou C., Tsipilis S., Gallos P., Jahaj E., Orfanos S.E., Kotanidou A., Dimopoulou I. Comparative Evaluation and Prognostic Utility of Neuronal Injury Biomarkers in COVID-19 Patients: A Prospective Study. Shock. 2022;58:507&#x2013;513. doi: 10.1097/SHK.0000000000002017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0000000000002017</ArticleId><ArticleId IdType="pubmed">36548642</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh S.X.T., Lee J.K.W. S100B as a Marker for Brain Damage and Blood-Brain Barrier Disruption Following Exercise. Sports Med. 2014;44:369&#x2013;385. doi: 10.1007/s40279-013-0119-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-013-0119-9</ArticleId><ArticleId IdType="pubmed">24194479</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennol M.P., Ashton N.J., Moreno-P&#xe9;rez O., Garc&#xed;a-Ayll&#xf3;n M.S., Ramos-Rincon J.M., Andr&#xe9;s M., Le&#xf3;n-Ram&#xed;rez J.M., Boix V., Gil J., Blennow K., et al. Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes. Int. J. Mol. Sci. 2023;24:2715. doi: 10.3390/ijms24032715.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24032715</ArticleId><ArticleId IdType="pmc">PMC9917569</ArticleId><ArticleId IdType="pubmed">36769057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F., Mazibuko N., Williams S.C., Barnby J.M., Hellyer P., et al. Cognitive Deficits in People Who Have Recovered from COVID-19. eClinicalMedicine. 2021;39:101044. doi: 10.1016/j.eclinm.2021.101044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazzini B., Battaglini D., Carenzo L., Pelosi P., Cecconi M., Puthucheary Z. Physical and Psychological Impairment in Survivors of Acute Respiratory Distress Syndrome: A Systematic Review and Meta-Analysis. Br. J. Anaesth. 2022;129:801&#x2013;814. doi: 10.1016/j.bja.2022.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bja.2022.08.013</ArticleId><ArticleId IdType="pubmed">36116979</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Soddu D., Balbo P.E., Baricich A., Zeppegno P., Avanzi G.C., Baldon G., Bartolomei G., Battaglia M., Battistini S., et al. Respiratory and Psychophysical Sequelae among Patients with COVID-19 Four Months after Hospital Discharge. JAMA Netw. Open. 2021;4:e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasannejad C., Ely E.W., Lahiri S. Long-Term Cognitive Impairment after Acute Respiratory Distress Syndrome: A Review of Clinical Impact and Pathophysiological Mechanisms. Crit. Care. 2019;23:352. doi: 10.1186/s13054-019-2626-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-019-2626-z</ArticleId><ArticleId IdType="pmc">PMC6852966</ArticleId><ArticleId IdType="pubmed">31718695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupien S.J., McEwen B.S., Gunnar M.R., Heim C. Effects of Stress throughout the Lifespan on the Brain, Behaviour and Cognition. Nat. Rev. Neurosci. 2009;10:434&#x2013;445. doi: 10.1038/nrn2639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2639</ArticleId><ArticleId IdType="pubmed">19401723</ArticleId></ArticleIdList></Reference><Reference><Citation>Franks K.H., Rowsthorn E., Bransby L., Lim Y.Y., Chong T.T.J., Pase M.P. Association of Self-Reported Psychological Stress with Cognitive Decline: A Systematic Review. Neuropsychol. Rev. 2023;33:856&#x2013;870. doi: 10.1007/s11065-022-09567-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-022-09567-y</ArticleId><ArticleId IdType="pubmed">36456767</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Maes M. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Encephalomyelitis Disseminata/Multiple Sclerosis Show Remarkable Levels of Similarity in Phenomenology and Neuroimmune Characteristics. BMC Med. 2013;11:205. doi: 10.1186/1741-7015-11-205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-11-205</ArticleId><ArticleId IdType="pmc">PMC3847236</ArticleId><ArticleId IdType="pubmed">24229326</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Fagioli L.R., Doolittle T.H., Gandek B., Gleit M.A., Guerriero R.T., Kornish R.J., Ware N.C., Ware J.E., Bates D.W. Health Status in Patients with Chronic Fatigue Syndrome and in General Population and Disease Comparison Groups. Am. J. Med. 1996;101:281&#x2013;290. doi: 10.1016/S0002-9343(96)00174-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(96)00174-X</ArticleId><ArticleId IdType="pubmed">8873490</ArticleId></ArticleIdList></Reference><Reference><Citation>Astin R., Banerjee A., Baker M.R., Dani M., Ford E., Hull J.H., Lim P.B., McNarry M., Morten K., O&#x2019;Sullivan O., et al. Long COVID: Mechanisms, Risk Factors and Recovery. Exp. Physiol. 2023;108:12&#x2013;27. doi: 10.1113/EP090802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP090802</ArticleId><ArticleId IdType="pmc">PMC10103775</ArticleId><ArticleId IdType="pubmed">36412084</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>